Furthermore, the monoclonal antibody TSPAN8–LEL IgG was shown to significantly reduce the incidence of epithelial ovarian cancer metastasis in vivo without causing severe toxicity [177]. The gene discussed is TSPAN8; the disease is ovarian carcinoma.